Noxopharm Limited (ASX:NOX) Executive Chairman and CEO, Dr Graham Kelly, Chief Medical Officer, Dr Gisela Mautner and Chief Commercial Officer, Alex Hunter provide an update on the company’s progress, clinical trials and strategy.
- Corporate overview
- Clinical development program
- Drug pipeline program
- Clinical development strategy
- Commercial and financial perspective